Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Outcomes Based on Age in Patients With Metastatic Renal Cell Carcinoma Treated With First Line Targeted Therapy or Checkpoint Immunotherapy: Older Patients More Prone to ToxicityJ Geriatr Oncol 2020 Dec 31;[EPub Ahead of Print], CK Hermansen, F Donskov
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.